Smith Group Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $878K | Buy |
58,430
+15,430
| +36% | +$232K | 0.06% | 97 |
|
|
2025
Q1 | $567K | Sell |
43,000
-400
| -0.9% | -$5.28K | 0.04% | 125 |
|
|
2024
Q4 | $685K | Buy |
+43,400
| New | +$685K | 0.05% | 110 |
|
|
2022
Q1 | $629K | Sell |
56,450
-500
| -0.9% | -$5.57K | 0.03% | 107 |
|
|
2021
Q4 | $745K | Sell |
56,950
-1,500
| -3% | -$19.6K | 0.03% | 114 |
|
|
2021
Q3 | $761K | Buy |
58,450
+6,950
| +13% | +$90.5K | 0.04% | 103 |
|
|
2021
Q2 | $757K | Buy |
51,500
+3,200
| +7% | +$47K | 0.04% | 98 |
|
|
2021
Q1 | $593K | Buy |
48,300
+3,200
| +7% | +$39.3K | 0.03% | 121 |
|
|
2020
Q4 | $643K | Sell |
45,100
-4,000
| -8% | -$57K | 0.04% | 113 |
|
|
2020
Q3 | $683K | Sell |
49,100
-11,650
| -19% | -$162K | 0.04% | 115 |
|
|
2020
Q2 | $644K | Sell |
60,750
-10,650
| -15% | -$113K | 0.04% | 120 |
|
|
2020
Q1 | $576K | Buy |
+71,400
| New | +$576K | 0.03% | 115 |
|
|
2014
Q2 | – | Sell |
-28,975
| Closed | -$254K | – | 444 |
|
|
2014
Q1 | $254K | Sell |
28,975
-750
| -3% | -$6.58K | 0.01% | 210 |
|
|
2013
Q4 | $244K | Hold |
29,725
| – | – | 0.01% | 209 |
|
|
2013
Q3 | $225K | Hold |
29,725
| – | – | 0.01% | 219 |
|
|
2013
Q2 | $225K | Buy |
+29,725
| New | +$225K | 0.01% | 224 |
|